Neurobiological Technologies, Inc. Share Price Other OTC
Equities
NTII
US64124W3043
Pharmaceuticals
Sales 2008 | 14.76M 1.16B | Sales 2009 | 26.35M 2.07B | Capitalization | 18.18M 1.43B |
---|---|---|---|---|---|
Net income 2008 | -16M -1.26B | Net income 2009 | 3M 236M | EV / Sales 2008 | 0.56 x |
Net cash position 2008 | 29.98M 2.36B | Net cash position 2009 | 24.05M 1.89B | EV / Sales 2009 | -0.22 x |
P/E ratio 2008 |
-1.69
x | P/E ratio 2009 |
5.82
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |